NewHold Investment Corp IV (NYSE:NHIV) closed its initial public offering on April 16, 2026, raising $201,250,000 from 20,125,000 units at $10.00 each, including full exercise of a 2,625,000-unit over-allotment option. Each unit contains one Class A ordinary share and one-third of a warrant.
Units trade on Nasdaq Global Market as NHIVU; once separated, shares and warrants are expected to trade as NHIV and NHIVW. Proceeds are intended to fund the company’s initial business combination.
NewHold Investment Corp IV (NHIV) priced a $175.0 million initial public offering of 17,500,000 units at $10.00 per unit on April 14, 2026, with each unit containing one Class A ordinary share and one-third of a redeemable warrant.
Units begin trading on Nasdaq Global Market as NHIVU on April 15, 2026; Class A shares and warrants are expected to trade as NHIV and NHIVW after separation. The underwriter has a 45-day 15% over-allotment option to purchase up to 2,625,000 additional units. The offering is expected to close April 16, 2026.